Carole A. Federico, PhD

Carole Federico completed an MSc in Bioethics, followed by a PhD in Experimental Medicine at McGill University. Her dissertation applied meta-analytic techniques to understand inefficiencies in the clinical translation of pain drugs. In general, Carole’s research focuses on rigor and reproducibility in biomedical science, with a special interest in the conditions of ethical animal research and how preclinical findings affect uncertainty at the transition between preclinical and clinical testing. As a GSK.ai-Stanford Ethics Fellow, her work revolves around the ethics of AI-enabled drug discovery and development.